Medicine
Esmolol 100 mg/10 mL injection
Esmolol 100 mg/10 mL injection is a generic prescription medicine for intravenous use, made by 10 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from freezing. Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Esmolol
- Brand
- Sold under the generic name
- Strength
- 100 mg/10 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 25 vials of 10 mL, 10 vials of 10 mL, 10 mL and 13 more
- Manufacturers
- EugiaIndiaGland PharmaIndiaHealthFirstFresenius KabiHenry ScheinMedical Purchasing SolutionsBaxter HealthcareMylan InstitutionalProPharma DistributionRemedyrepack
- Origin register
- US FDA, United States
- Storage
- Protect from freezing. Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C07AB09 Esmolol
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 December 1986
- Identifiers
- RxCUI 1736546, 979432, 1736541DailyMed set ID 789730fa-eaca-4986-e053-2a91aa0a5339, ac22475d-2d78-469f-9435-b403ac4ee380, 9c1e3a64-0ef0-4071-ad6f-63ff8789b198 +11NDC 51662-1322, 55150-194, 0404-9785 +12Application ANDA076474, ANDA205520, NDA019386 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 25 vial, single-dose in 1 carton / 10 mL in 1 vial, single-dose | 55150-194-10 | EugiaIndia | 23 July 2015 |
| 25 vial in 1 carton / 10 mL in 1 vial | 68083-211-25 | Gland PharmaIndia | 19 August 2019 |
| 25 vial, single-dose in 1 tray / 10 mL in 1 vial, single-dose | 63323-652-10 | Fresenius Kabi | 30 November 2004 |
| 25 vial, single-dose in 1 tray / 10 mL in 1 vial, single-dose | 63323-661-14 | Fresenius Kabi | 13 January 2025 |
| 25 vial in 1 carton / 10 mL in 1 vial | 10019-120-01 | Baxter Healthcare | 31 December 1986 |
| 10 vial in 1 carton / 10 mL in 1 vial | 67457-182-10 | Mylan Institutional | 29 May 2007 |
| 10 mL in 1 vial | 51662-1322-1 | HealthFirst | 19 October 2018 |
| 10 mL in 1 vial, single-dose | 51662-1371-1 | HealthFirst | 8 December 2019 |
| 10 mL in 1 vial, single-dose | 51662-1444-1 | HealthFirst | 22 December 2019 |
| 25 pouch in 1 case / 1 vial, single-dose in 1 pouch / 10 mL in 1 vial, single-dose | 51662-1444-3 | HealthFirst | 12 September 2022 |
| 1 vial in 1 bag / 10 mL in 1 vial | 0404-9785-10 | Henry Schein | 10 June 2025 |
| 1 vial, single-dose in 1 bag / 10 mL in 1 vial, single-dose | 0404-9858-10 | Henry Schein | 10 January 2022 |
| 1 vial, single-dose in 1 bag / 10 mL in 1 vial, single-dose | 71872-7049-1 | Medical Purchasing Solutions | 19 February 2018 |
| 1 vial in 1 bag / 10 mL in 1 vial | 71872-7136-1 | Medical Purchasing Solutions | 19 April 2018 |
| 10 mL in 1 vial, single-dose | 84549-194-10 | ProPharma Distribution | 27 August 2025 |
| 25 vial, single-dose in 1 carton / 10 mL in 1 vial, single-dose | 70518-4410-0 | Remedyrepack | 29 July 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 31 December 1986 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Esmolol 100 mg/10 mL injection.
Other strengths and forms of Esmolol
Clinical summary
Esmolol is a beta-adrenergic blocker indicated for the short-term treatment of control of ventricular rate in supraventricular tachycardia including atrial fibrillation and atrial flutter and control of heart rate in noncompensatory sinus tachycardia, among other approved uses. MedsAcross supplies Esmolol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about EsmololFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- BREVIBLOC prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
Need Esmolol 100 mg/10 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.